• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597081)   Today's Articles (5277)   Subscriber (49345)
For: Leinonen M, Söderberg K, Olivecrona H, Aldén Raboisson M, Sibley C, Brewer C, Plass N, King K, Zalewski C, Kim J, Stone D, Chapelle D, Goldbach-Mansky R. SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.2164] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Number Cited by Other Article(s)
1
The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS). Pediatr Rheumatol Online J 2014. [PMCID: PMC4184312 DOI: 10.1186/1546-0096-12-s1-p76] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA